Arcus Biosciences (RCUS) Return on Equity [ROE] (2018 - 2026)
Arcus Biosciences (RCUS) reported Return on Equity [ROE] of -93.12% for Q2 2026, down 37.93 percentage points from -55.19% a year earlier and down 29.22 percentage points from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, Arcus Biosciences posted Return on Equity [ROE] of -63.26%, down 3.49 percentage points from FY2024.
- Return on Equity [ROE] has declined for four consecutive years, with a five-year change of -26.32 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -59.77% in FY2024 (-4.90 pp), -54.87% in FY2023 (-19.25 pp), -35.62% in FY2022 (-43.51 pp) and 7.89% in FY2021 (+44.82 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] in data going back to Q1 2018.
- Year over year, Return on Equity [ROE] gained in three of the last eight quarters, with an average year-over-year change of -12.41 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q3 2022 (a gain of 59.56 percentage points); the low point was Q3 2023 (a drop of 64.96 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -63.90% (Q1 2026), -66.17% (Q4 2025) and -69.24% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Arcus Biosciences | 3.11 Bn | -229.58 Mn | - | -93.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -93.12% |
| Mar 31, 2026 | -63.90% |
| Dec 31, 2025 | -66.17% |
| Sep 30, 2025 | -69.24% |
| Jun 30, 2025 | -55.19% |
| Mar 31, 2025 | -76.97% |
| Dec 31, 2024 | -53.90% |
| Sep 30, 2024 | -45.00% |
| Jun 30, 2024 | -37.11% |
| Mar 31, 2024 | -39.52% |
| Dec 31, 2023 | -62.53% |
| Sep 30, 2023 | -53.96% |
| Jun 30, 2023 | -49.23% |
| Mar 31, 2023 | -44.39% |
| Dec 31, 2022 | -39.38% |
| Sep 30, 2022 | 11.00% |
| Jun 30, 2022 | 8.62% |
| Mar 31, 2022 | 7.03% |
| Dec 31, 2021 | 7.66% |
| Sep 30, 2021 | -48.56% |
API Access
Arcus Biosciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();